GSK plc
Search results
At AstraZeneca, we’re committed to diving deep into the root cause of heart failure to determine the changes we need to make in ways we treat this disease, transform care and ultimately improve outcomes. Martin Cowie, Interim Senior Vice President Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D ...
At AstraZeneca, sustainability is part of our DNA, embedded in everything we do, from the lab to the patient. Working in partnership with all our stakeholders, we are harnessing the power of science and innovation to deliver life-changing medicines in a way that is respectful of our planet. Our sustainability strategy is guided by three ...
AstraZeneca plc (/ ˌ æ s t r ə ˈ z ɛ n ə k ə /) (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.. The company was founded in 1999 ...
11 hours ago · Cheering the announcement, shares of AstraZeneca Pharma India rallied 13% to 7064.65 on July 23, 2024. On a year-to-date basis, the scrip has gained nearly 28%.
AstraZeneca Pharma India Limited (AZPIL) is the operating company and covers manufacturing, sales and marketing activities of the company in India. It is a listed company and is a subsidiary of AstraZeneca Plc, UK. It has a workforce of over 900 employees across the country that is committed to deliver life-changing medicines to patients ...
Jun 13, 2022 · The AstraZeneca vaccine is safe and effective at protecting people from the extremely serious risks of COVID-19, including death, hospitalization and severe disease. Read the 16 April 2021 statement of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine for reports of very rare side effects.
1. AstraZeneca. Vaxzevria shown in expert review to provide equally effective protection against COVID-19 hospitalisation and death as mRNA vaccines [Last accessed: October 2022].
Dec 17, 2021 · AstraZeneca and Amgen’s Tezspire (tezepelumab-ekko) has been approved in the US for the add-on maintenance treatment of adult and paediatric patients aged 12 years and older with severe asthma. 1. Tezspire was approved following a Priority Review by the US Food and Drug Administration (FDA) and based on results from the PATHFINDER clinical trial programme. The application included results from the pivotal NAVIGATOR Phase III trial in which Tezspire demonstrated superiority across every ...
Haidar G et al. Prospective evaluation of coronavirus cisease 2019 (COVID-19) vaccine responses across a broad spectrum of immunocompromising conditions: the COVID-19 vaccination in the immunocompromised study (COVICS). Clin Infect Dis. 2022 75 (1):3630-e644. doi: 10:1093/cid/ciac103.
Oct 27, 2021 · The AstraZeneca COVID-19 vaccine, now called Vaxzevria, is a viral vector vaccine, just like the Johnson & Johnson vaccine. It uses a chimpanzee adenovirus to carry spike proteins from the ...
